image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

NMC - Closing in on £30 landmark

December 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NMC
  • Price:
  • 2962p
The shares hit a new high of 2944p after it announced it has received all regulatory approvals for its long-term care facility in Jeddah, Saudi Arabia, which will add significant capacity. It plans to acquire a hospital in the North West region (city of Ha’il) and southern regions (city of Najran), each with 100 bed capacity costing US$40m in total. A third facility in the Western province of 170 beds is at the greenfield project stage.The strong news flow continues to boost the shares. Highlighted originally at 363p in December ‘13 and several times since, the shares have gained 716%. We are happy to run profits. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X